About Cardiosense
Cardiosense is a company based in Chicago (United States) founded in 2020 by Amit Gupta, Avi Kazen, and Andrew Carek. Cardiosense has raised $15.1 million across 1 funding round from investors including UnityPoint Health, Broadview Ventures and Hatteras Venture Partners. Cardiosense offers products and services including CardioTag Sensor, Wavesense Platform, and Clinical AI. Cardiosense operates in a competitive market with competitors including Tyto Care, AliveCor, Edwards Lifesciences, BioIntelliSense and Endotronix, among others.
- Headquarter Chicago, United States
- Founders Amit Gupta, Avi Kazen, Andrew Carek
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardiosense, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.1 M (USD)
in 1 rounds
-
Latest Funding Round
$15.1 M (USD), Series A
Dec 08, 2022
-
Investors
UnityPoint Health
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardiosense
Cardiosense offers a comprehensive portfolio of products and services, including CardioTag Sensor, Wavesense Platform, and Clinical AI.
Medical-grade wearable for wireless patient monitoring and data collection.
Device-agnostic system for aggregating and analyzing physiological sensor data.
Applies deep learning to raw waveforms for early cardiac disease detection.
People of Cardiosense
Unlock access to complete
Unlock access to complete
Funding Insights of Cardiosense
Cardiosense has successfully raised a total of $15.1M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.1 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cardiosense
Cardiosense has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include UnityPoint Health, Broadview Ventures and Hatteras Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UnityPoint Health is recognized for providing comprehensive healthcare services.
|
Locked | Locked | Locked | |
|
Seed-stage life sciences investments are made in the US.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked |
Investor details for Cardiosense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cardiosense
Investment portfolio details for Cardiosense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cardiosense
Detailed financials for Cardiosense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardiosense Comparisons
Peer comparison for Cardiosense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cardiosense
Cardiosense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, AliveCor, Edwards Lifesciences, BioIntelliSense and Endotronix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
Detailed competitors of Cardiosense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardiosense
Complete news archive for Cardiosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardiosense
Cardiosense was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Cardiosense is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Amit Gupta is the current CEO of Cardiosense. They have also founded this company.
Cardiosense is a funded company, having raised a total of $15.1M across 1 funding round to date.
Cardiosense was founded in 2020 and is headquartered in Chicago, United States. Operations focus on the healthcare sector, where AI-based devices for cardiac monitoring are supplied to providers. A physiological waveform data platform is being developed, incorporating multi-modal sensors and AI algorithms to generate predictive biomarkers. These support pre-symptomatic disease detection and facilitate personalized therapy options.
Cardiosense's top competitors include Tyto Care, AliveCor and Endotronix.
Cardiosense offers CardioTag Sensor, Wavesense Platform, and Clinical AI.
Cardiosense has 6 investors. Key investors include UnityPoint Health, Broadview Ventures, Hatteras Venture Partners, Laerdal Million Lives Fund, and Portal Innovations.